Previous 10 | Next 10 |
Oppenheimer initiates coverage on thinly traded nano cap Infinity Pharmaceuticals ( INFI +3.6% ) with an Outperform rating and $3 (74% upside) price target. More news on: Infinity Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
CAMBRIDGE, Mass. , May 29, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that members of the management team will be participating in the 2019 BIO International Convention at Pennsylvania Convention Center, Philadelphia, PA. Adelene Perkins , ...
CAMBRIDGE, Mass. , May 16, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that Adelene Perkins , Infinity Pharmaceutical's Chief Executive Officer, will present at the B. Riley FBR Institutional Investor Conference on Thursday, May 23, 2019 , at ...
Infinity Pharmaceuticals, Inc. (INFI) Q1 2019 Earnings Conference Call May 07, 2019 04:30 PM ET Company Participants Jayne Kauffman - Senior Executive Coordinator Adelene Perkins - CEO Sam Agresta - Chief Medical Officer Jeff Kutok - Chief Scientific Officer Conference Call...
Infinity Pharmaceuticals (NASDAQ: INFI ): Q1 GAAP EPS of -$0.24 misses by $0.08 . More news on: Infinity Pharmaceuticals, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
CAMBRIDGE, Mass. , May 7, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its first quarter 2019 financial results and provided an update on the company, including its progress in expanding the breadth and depth of the development of IPI-549 ...
CAMBRIDGE, Mass. , April 30, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, May 7 , at 4:30 p.m. ET to review its first quarter 2019 financial results and provide an update on the company. A live webcast of the confere...
CAMBRIDGE, Mass. , April 2, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that Adelene Perkins , Infinity Pharmaceutical's Chief Executive Officer, will present at the 18 th Annual Needham Healthcare Conference on Tuesday, April 9, 2019 , at 3...
Infinity Pharmaceuticals Inc. (INFI) Q4 2018 Results Earnings Conference Call March 14, 2019 08:00 AM ET Company Participants Jayne Kauffman - Senior Executive Coordinator Adelene Perkins - CEO Samuel Agresta - CMO Lawrence Bloch - President Jeffery Kutok - Chief Scientific...
Atossa Genetics (NASDAQ: ATOS ) +223% on expanded access for Endoxifen. More news on: Atossa Genetics Inc., Hancock Jaffe Laboratories, Inc., Safe-T Group Ltd, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Infinity Pharmaceuticals Inc. Company Name:
INFI Stock Symbol:
NASDAQ Market:
Infinity Pharmaceuticals Inc. Website:
Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - Infinitum Copper Corp. (TSXV: INFI) (OTCQB: INUMF) (" Infinitum " or the " Company ") is pleased to announce that it has received acceptance from the TSX Venture Exchange (the " Exchange ") of the previously announced consolidation ...
VANCOUVER, BC / ACCESSWIRE / April 3, 2024 / Infinitum Copper Corp. (TSXV:INFI, OTCQB:INUMF) (" Infinitum " or the " Company ") is pleased to announce the details of a proposed consolidation of its common shares. On March 21, 2024, in accordance with the constating documents of the Company, the ...
VANCOUVER, BC / ACCESSWIRE / March 6, 2024 / Infinitum Copper Corp. (TSXV:INFI)(OTCQB:INUMF) (" Infinitum " or the " Company "). Further to the Company's news release of March 5, 2024 (the " March 5, 2024 News Release "), this is to advise that the Company has amended the terms of its private pl...